Resmed Plans Earnings Webcast for First Quarter Fiscal 2026

Exciting Earnings Announcement from Resmed
Resmed, a leader in innovative health technologies, has announced plans to release its financial and operational results for the first quarter of fiscal year 2026. This release will occur on Thursday, October 30, and following the announcement, the management team will host an engaging webcast to discuss the results and provide additional insights.
Details of the Earnings Webcast
Expect to tune in on October 30, where Resmed will offer a comprehensive overview of their performance. The webcast is set to begin at 1:30 p.m. PDT, or 4:30 p.m. EDT. For international audiences, this corresponds to 8:30 p.m. GMT in London and 7:30 a.m. AEDT in Sydney on the following day.
How to Join the Webcast
Discover how to access the earnings webcast by utilizing the provided link on Resmed's investor relations website. It's important to note that Resmed solely offers access through this link, ensuring a secure platform for listeners.
Post-Webcast Replay Information
For those who cannot join live, a replay will be made available on Resmed’s website approximately two hours after the webcast concludes. Additionally, a phone replay option will be provided starting three hours post-webcast, which can be accessed until November 13.
About Resmed and Its Mission
Resmed (NYSE: RMD, ASX: RMD) is dedicated to transforming healthcare with life-changing technologies that people genuinely appreciate. With a relentless focus on innovation, Resmed empowers millions across 140 countries to pursue healthier, happier lives. Its cutting-edge AI-powered digital health solutions, along with its cloud-connected devices, make home healthcare increasingly personalized and effective.
The Vision of Resmed
Resmed envisions a future where everyone can unlock their full potential through improved sleep and breathing, all within the comfort of their own homes. By setting the benchmark in sleep health, Resmed aims to redefine what home healthcare can achieve.
Investor and Media Relations
For any inquiries, investors can reach out to Resmed at +1 858.221.3304 or via email at investorrelations@resmed.com. For media-related questions, contact +1 619.510.1281 or email news@resmed.com.
Frequently Asked Questions
When will Resmed release its earnings report?
Resmed will release its earnings report on October 30, 2025.
What time will the earnings webcast start?
The webcast will start at 1:30 p.m. PDT (4:30 p.m. EDT).
How can I access the earnings webcast?
You can access the earnings webcast via the link provided on Resmed's investor relations page.
Will there be a replay available for the webcast?
Yes, a replay will be available on Resmed’s website two hours after the webcast.
What is Resmed's commitment to healthcare?
Resmed is committed to innovating health technologies that empower people to live healthier lives.
About The Author
Contact Olivia Taylor privately here. Or send an email with ATTN: Olivia Taylor as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.